Related Experiment Video
Updated: May 9, 2026

06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Abdominal wall desmoid tumors: A case report.
Jin-Hui Ma1, Zhen-Hai Ma, Xue-Feng Dong
1Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, P.R. China.
Oncology Letters
|July 9, 2013
Summary
Desmoid tumors (DTs) are rare, locally invasive soft tissue neoplasms. Surgical resection offers a good prognosis for abdominal wall DTs, as demonstrated by this case report.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Desmoid tumors (DTs) are rare, locally aggressive soft tissue neoplasms with no metastatic potential.
- DTs constitute 3% of soft tissue tumors and 0.03% of all neoplasms, often occurring in females of reproductive age.
- Abdominal DTs can be sporadic or linked to familial adenomatous polyposis (FAP).
Purpose of the Study:
- To present a case of abdominal wall desmoid tumor in a female patient with no relevant family history.
- To highlight the diagnostic and treatment approach for abdominal desmoid tumors.
- To contribute to the understanding of desmoid tumor management.
Main Methods:
- Case report of a female patient diagnosed with an abdominal wall desmoid tumor.
- Diagnostic workup included medical history, physical examination, and CT scan.
- Treatment involved radical resection of affected musculature and polypropylene mesh repair.
Main Results:
- Histological diagnosis confirmed desmoid tumor.
- The patient achieved complete remission and remains in good health post-surgery without further treatment.
- This case illustrates successful surgical management of an abdominal DT.
Conclusions:
- Desmoid tumors require prompt diagnosis and management due to their aggressive local invasion and recurrence potential.
- Radical surgery is the primary treatment for desmoid tumors, with radiotherapy potentially reducing recurrence rates.
- Further research and multicenter trials are essential for improving desmoid tumor management.
